Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 170

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

International consensus on initial screening and follow-up of asymptomatic SDHx mutation carriers

Open access
Amar, Laurence, Pacak, Karel, Steichen, Olivier, Akker, Scott A., Aylwin, Simon J. B., Baudin, Eric, Buffet, Alexandre, Burnichon, Nelly, Clifton-Bligh, Roderick J., Dahia, Patricia L. M., Fassnacht, Martin, Grossman, Ashley B., Herman, Philippe, Hicks, Rodney J., Januszewicz, Andrzej, Jimenez, Camilo, Kunst, Henricus P. M., Lewis, Dylan, Mannelli, Massimo, Naruse, Mitsuhide, Robledo, Mercedes, Taïeb, David, Taylor, David R., Timmers, Henri J. L. M., Treglia, Giorgio, Tufton, Nicola, Young, William F., Lenders, Jacques W. M., Gimenez-Roqueplo, Anne-Paule, Lussey-Lepoutre, Charlotte · 2021 · Nature Reviews Endocrinology

Abstract

Approximately 20% of patients diagnosed with a phaeochromocytoma or paraganglioma carry a germline mutation in one of the succinate dehydrogenase (SDHx) genes (SDHA,SDHB,SDHC and SDHD), which encode the four subunits of the SDH enzyme. When a pathogenic SDHx mutation is identified in an affected patient, genetic counselling is proposed for first-degree relatives. Optimal initial evaluation and follow-up of people who are asymptomatic but might carry SDHx mutations have not yet been agreed. Thus, we established an international consensus algorithm of clinical, biochemical and imaging screening at diagnosis and during surveillance for both adults and children. An international panel of 29 experts from 12 countries was assembled, and the Delphi method was used to reach a consensus on 41 statements. This Consensus Statement covers a range of topics, including age of first genetic testing, appropriate biochemical and imaging tests for initial tumour screening and follow-up, screening for rare SDHx-related tumours and management of elderly people who have an SDHx mutation. This Consensus Statement focuses on the management of asymptomatic SDHx mutation carriers and provides clinicians with much-needed guidance. The standardization of practice will enable prospective studies in the near future.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41574-021-00492-3

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

See all 170

Metadata

Authors
Amar, L., Pacak, K., Steichen, O., Akker, S. A., Aylwin, S. J. B., Baudin, E., Buffet, A., Burnichon, N., Clifton-Bligh, R. J., Dahia, P. L. M., Fassnacht, M., Grossman, A. B., Herman, P., Hicks, R. J., Januszewicz, A., Jimenez, C., Kunst, H. P. M., Lewis, D., Mannelli, M., Naruse, M., Robledo, M., Taïeb, D., Taylor, D. R., Timmers, H. J. L. M., Treglia, G., Tufton, N., Young, W. F., Lenders, J. W. M., Gimenez-Roqueplo, A.-P., & Lussey-Lepoutre, C.
Venue
Nature Reviews Endocrinology
Published
2021-05-21
Volume
17
Issue
7
Pages
435-444
ISSN
  • 1759-5029 (ISSN-L)
  • 1759-5037
OpenAlex
W3162562470
Cited by
170
References
8
FWCI
8.62
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: International consensus on initial screening and follow-up of asymptomatic SDHx mutation carriers. https://app.cochat.ai/papers/10.1038/s41574-021-00492-3
The paper
Amar, L., Pacak, K., Steichen, O., Akker, S. A., Aylwin, S. J. B., Baudin, E., Buffet, A., Burnichon, N., Clifton-Bligh, R. J., Dahia, P. L. M., Fassnacht, M., Grossman, A. B., Herman, P., Hicks, R. J., Januszewicz, A., Jimenez, C., Kunst, H. P. M., Lewis, D., Mannelli, M., . . . Lussey-Lepoutre, C. (2021). International consensus on initial screening and follow-up of asymptomatic SDHx mutation carriers. Nature Reviews Endocrinology. https://doi.org/10.1038/s41574-021-00492-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.